Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Luis Grosembacher"'
Autor:
Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 55, Iss 3Sup, Pp 41-59 (2021)
The exponential increase in the prevalence of diabetes mellitus (DM) throughout the world also includes the increase in people with type 1 diabetes (T1D)1. This disease is characterized by the autoimmune and progressive destruction of pancreatic Beta
Externí odkaz:
https://doaj.org/article/2ef86263dd1d4b2f8a3d7d7c3359b119
Autor:
Adriana Álvarez, Andrea Kozak, Lucas Costa, Guillermo Alzueta, Juan Bauchi, Claudia De Boni, Guillermo Dieuzeide, Olga Escobar, Teresita García, Patricia Mascaró, Olguita Vera, Diego González, Bibiana Fabre, Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3, Pp 132-139 (2020)
Introduction: depression (DP) has a high prevalence in patients with type 1 diabetes mellitus (DM1) and is associated with negative clinicals consequences like more cardiovascular morbimortality and chronic complications. There are few studies publis
Externí odkaz:
https://doaj.org/article/35692f16c60f4673942f5d1e6e1bf8b9
Autor:
León Litwak, Nancy Carreño, Rodrigo Carnero, Alejandro Dain, Luis Grosembacher, Carla Musso, Adrián Proietti, Lucas Rista, Gabriela Rovira, Graciela Rubin, María Ruiz, Antonio Saleme, Liliana Trifone, José Costa Gil
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3, Pp 140-154 (2020)
The tools to assess the degree of glycemic control were modified lately. Glycosylated Hemoglobin (HbA1c), the gold standard, reflects the glycemic control of the last 3 months retrospectively, without expressing glycemic variability. Self-blood gluco
Externí odkaz:
https://doaj.org/article/e74df672411742c48b6635738453d5c5
Autor:
Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 56, Iss 3Sup, Pp 3-3 (2022)
The ideal or most appropriate insulin therapy system is one that achieves or comes close to maintaining blood glucose within normal physiological ranges. Reaching this goal is the current challenge in Biotechnology applied to Diabetes. The developmen
Externí odkaz:
https://doaj.org/article/3f6e2b6dbf34405398297ecd0f8b98a4
Autor:
Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 55, Iss 2, Pp 35-36 (2021)
The COVID-19 pandemic that is going through the entire world caused a situation of global crisis in all health systems. This crisis forced us to make emergent changes to achieve adequate inpatient care in critical and non-critical areas. Therefore, t
Externí odkaz:
https://doaj.org/article/462b4a00aac9444f928f1739c00f2bc2
Autor:
Luis Grosembacher, Roxana Groppa, Javier Giunta, Adriana Mabel Álvarez, Lina Inés Capurro, María Montserrat Castex, Cintia Rodríguez, Julia García Arabehety, Patricia Liliana Duette, Lucas Costa, Sung Ho Hyon
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3Sup, Pp 105-105 (2020)
Introduction: Pancreas transplant alone (PTA) restores glycemic control with exogenous insulin independence in the after transplantation (posTx) in patients with type 1 diabetes mellitus (T1D). Between an 8% and 10% of the pancreas transplants cases
Externí odkaz:
https://doaj.org/article/7ba4c1de9b8a481f9e94995b3bd38791
P50 Short term glycemic control with a hybrid closed loop system in individuals with type 1 diabetes
Autor:
Adrián Proietti, Andrea Daghero, María Laura Kabakian, María Paula Paz Povedano, María Marcela Raggio, Graciela Rubín, Antonio Saleme, Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 54, Iss 3Sup, Pp 155-155 (2020)
Background: Despite recent technological advances, optimal glycemic control remains a challenge in people with type 1 diabetes (T1D). Hybrid closed loop (HCL) system with algorithm-derived automated adjustment of insulin delivery aims to improve glyc
Externí odkaz:
https://doaj.org/article/c38ec77cbe594345b31d56f3be1995b7
Autor:
Luis Grosembacher
Publikováno v:
Revista de la Sociedad Argentina de Diabetes, Vol 53, Iss 2Sup, Pp 19-19 (2020)
The endocrine and exocrine pancreas come from the same embryonic button and live in the same organ: the pancreas. However, in practice it is usual to approach endocrine diseases, such as diabetes mellitus, and exocrine ones, such as pancreatitis, in
Externí odkaz:
https://doaj.org/article/497950212dc14198bae3a1cb86a43372
Autor:
Sung Ho Hyon, María Candela Ceballos, Mariana Barbich, Rosana Groppa, Luis Grosembacher, María Mercedes Vieiro, Laura Barcan, Salomon Algranati, Leon Litwak, Pablo F. Argibay M.D., Ph.D.
Publikováno v:
Cell Transplantation, Vol 13 (2004)
Here we report on the impact of completely unpurified islet transplantation on the portal vein pressure (PVP) and the hepatic biochemistry in the peritransplant period and on follow-up. Type I diabetic patients underwent simultaneous kidney and islet
Externí odkaz:
https://doaj.org/article/dfe2a304e3db4294a3e73834671109dd
Autor:
María Laura Kabakian, Marcela Raggio, Adrián Proietti, Antonio Saleme, Maria Paula Paz, Graciela Rubin, Luis Grosembacher
Publikováno v:
Diabetes Technology & Therapeutics. 24:220-226
The goal of this study was to assess the 6-months effectiveness of HCL on glycemic control in T1D patients in Latin America. An exploratory analysis of data prospectively collected from non-selected consecutive patients with T1D that initiated treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aaf7894b4768461fc82cc79e0343a30
https://doi.org/10.1089/dia.2021.0248
https://doi.org/10.1089/dia.2021.0248